AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: Time with older children - highest tertile at 3.5 years
Number of subjects: 259
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' own physical activity at 9 months
Number of subjects: 259
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: Time active with mum - highest tertile at 3.5 years
Number of subjects: 259
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: Time with older children - highest tertile at 4 months
Number of subjects: 259
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: Time free to move about - middle tertile at 19 months
Number of subjects: 259
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: More home equipment at 9 months
Number of subjects: 259
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: More home equipment at 3.5 years
Number of subjects: 259
Study 31829267 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal physical activity knowledge at 3.5 years
Number of subjects: 259
Study 28917370 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmanthus fragrans oil
Number of subjects: 361
Study 28917370 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit oil
Number of subjects: 361
Study 28917370 — intervention group
Group type: COMPARATOR
Intervention: Control group (no inhalation)
Number of subjects: 361
Study 28917370 — intervention group
Group type: COMPARATOR
Intervention: Vehicle group (essential-oil-less vapor)
Number of subjects: 361
Study 28917370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil
Number of subjects: 361
Study 25929192 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN/D5600 (70 mg/vitamin D3 5600 IU) once weekly
Number of subjects: 219
Study 25929192 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol (0.25 μg/day)
Number of subjects: 219
Study 25929192 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN/D5600
Number of subjects: 219
Study 25929192 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 219
Study 23643501 — intervention group
Group type: EXPERIMENTAL
Intervention: RTMCE
Number of subjects: 2014
Study 23643501 — intervention group
Group type: COMPARATOR
Intervention: CSE
Number of subjects: 2014
Study 20692843 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrocentesis combined with splint therapy
Number of subjects: 80
Study 20692843 — intervention group
Group type: COMPARATOR
Intervention: Rest therapy (restricting mouth opening, analgesic therapy)
Number of subjects: 80
Study 20692843 — intervention group
Group type: COMPARATOR
Intervention: Splint therapy
Number of subjects: 80
Study 20692843 — intervention group
Group type: COMPARATOR
Intervention: Arthrocentesis of the upper joint space
Number of subjects: 80
Study 19255014 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe Environment for Every Kid (SEEK) model of pediatric primary care
Number of subjects: 558
Study 19255014 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 558
Study 16899830 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine sublingual tablet
Number of subjects: 370
Study 16899830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study 15571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasburicase (recombinant urate oxidase)
Number of subjects: 0
Study 15571272 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol (standard treatment)
Number of subjects: 0
Study 15571272 — intervention group
Group type: COMPARATOR
Intervention: Urate oxidase (non-recombinant form)
Number of subjects: 0
Study 15571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasburicase
Number of subjects: 0
Study 11391695 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian model selection methodology applied to survival analysis
Number of subjects: 0
Study 11391695 — intervention group
Group type: COMPARATOR
Intervention: Bayesian model selection methodology
Number of subjects: 0
Study 9783530 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifazid (fixed-dose combination of rifampicin, isoniazid, and pyrazinamide)
Number of subjects: 16
Study 9783530 — intervention group
Group type: COMPARATOR
Intervention: Free combinations of rifampicin, isoniazid, and pyrazinamide
Number of subjects: 16
Study 7841973 — intervention group
Group type: EXPERIMENTAL
Intervention: Broxaterol (400 micrograms)
Number of subjects: 12
Study 7841973 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms)
Number of subjects: 12
Study 7841973 — intervention group
Group type: COMPARATOR
Intervention: Cardiopulmonary exercise test (CPX)
Number of subjects: 12
Study 7841973 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study 3180489 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 6.25 mg
Number of subjects: 7
Study 3180489 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 7
Study 3180489 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 25 mg
Number of subjects: 7
Study 3180489 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 50 mg
Number of subjects: 7
Study 3180489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 5309530 — intervention group
Group type: EXPERIMENTAL
Intervention: ID-Jet 1 vaccine (10(7.0) TCID(50)/ml)
Number of subjects: 140
Study 5309530 — intervention group
Group type: EXPERIMENTAL
Intervention: ID-Jet 1a vaccine (10(6.3) TCID(50)/ml)
Number of subjects: 140
Study 5309530 — intervention group
Group type: EXPERIMENTAL
Intervention: ID-Jet 2 vaccine (10(6.0) TCID(50)/ml)
Number of subjects: 140
Study 5309530 — intervention group
Group type: COMPARATOR
Intervention: Standard multiple-pressure technique
Number of subjects: 140
Study 31154945 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (ESCAPE trial)
Number of subjects: 286
Study 31154945 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (Quality Improvement and Clinical Research patients)
Number of subjects: 286
Study 31154945 — intervention group
Group type: COMPARATOR
Intervention: Control (ESCAPE trial)
Number of subjects: 286
Study 31154945 — intervention group
Group type: COMPARATOR
Intervention: Usual care (2016/2017 fiscal year)
Number of subjects: 286
Study 27465661 — intervention group
Group type: EXPERIMENTAL
Intervention: Rationale for SSB price increase as a user fee, effort to reduce obesity, strategy to offset health-care costs, or to protect children
Number of subjects: 494
Study 27465661 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages describing the price increase as a user fee or tax
Number of subjects: 494
Study 25433572 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine 0.125% with fentanyl 2 μg/mL at 37°C
Number of subjects: 54
Study 25433572 — intervention group
Group type: COMPARATOR
Intervention: Epidural bupivacaine 0.125% with fentanyl 2 μg/mL at 20°C
Number of subjects: 54
Study 23228072 — intervention group
Group type: EXPERIMENTAL
Intervention: Tall Man lettering, covered decimal points, avoiding trailing zeros with decimal units
Number of subjects: 3000
Study 23228072 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse duty duration
Number of subjects: 3000
Study 23228072 — intervention group
Group type: COMPARATOR
Intervention: Transcription error rates for inpatient medications
Number of subjects: 3000
Study 23228072 — intervention group
Group type: COMPARATOR
Intervention: Transcription error rates for discharge patient medications
Number of subjects: 3000
Study 23228072 — intervention group
Group type: COMPARATOR
Intervention: Error rate for labels of dispensed items
Number of subjects: 3000
Study 21889702 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurant Stent Graft System
Number of subjects: 150
Study 18771605 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (subanaesthetic doses)
Number of subjects: 24
Study 18771605 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental (subanaesthetic doses)
Number of subjects: 24
Study 18771605 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 24
Study 16673208 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning insulin glargine plus morning glimepiride (2, 3 or 4 mg)
Number of subjects: 624
Study 16673208 — intervention group
Group type: COMPARATOR
Intervention: Bedtime insulin glargine plus morning glimepiride (2, 3 or 4 mg)
Number of subjects: 624
Study 15194375 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg/dose every 14 days for five doses (group I, n = 107)
Number of subjects: 297
Study 15194375 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg/dose every 14 days for two doses (group II, n = 112)
Number of subjects: 297
Study 15194375 — intervention group
Group type: COMPARATOR
Intervention: No-antibody induction (group III, n = 78)
Number of subjects: 297
Study 11212085 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiroflor SRL gel (SRL)
Number of subjects: 161
Study 11212085 — intervention group
Group type: COMPARATOR
Intervention: Cremor Capsici Compositus FNA (CCC)
Number of subjects: 161
Study 9415947 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 9
Study 9415947 — intervention group
Group type: COMPARATOR
Intervention: No Sleep Deprivation (NSD)
Number of subjects: 9
Study 8280513 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners' clinical decision to give thrombolytic therapy
Number of subjects: 137
Study 8280513 — intervention group
Group type: COMPARATOR
Intervention: Electrocardiograph (ECG)
Number of subjects: 137
Study 2943192 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam, 0.2 mg/kg
Number of subjects: 31
Study 2943192 — intervention group
Group type: COMPARATOR
Intervention: Thiopental, 3.5 mg/kg
Number of subjects: 31
Study 31753727 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus docetaxel
Number of subjects: 530
Study 31753727 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 530
Study 29496242 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA (1 g)
Number of subjects: 90
Study 29496242 — intervention group
Group type: COMPARATOR
Intervention: Intravenous TXA (1 g)
Number of subjects: 90
Study 29496242 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 90
Study 27073205 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 610
Study 27073205 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 610
Study 24942531 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline physical inactivity
Number of subjects: 0
Study 24942531 — intervention group
Group type: EXPERIMENTAL
Intervention: Men's physical inactivity
Number of subjects: 0
Study 24942531 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's physical inactivity
Number of subjects: 0
Study 22619612 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric levobupivacaine 0.42%
Number of subjects: 20
Study 22619612 — intervention group
Group type: COMPARATOR
Intervention: Isobaric levobupivacaine 0.42%
Number of subjects: 20
Study 20850828 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser ablation
Number of subjects: 109
Study 20850828 — intervention group
Group type: COMPARATOR
Intervention: Photoselective vaporization
Number of subjects: 109
Study 18795687 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 28
Study 15813757 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based learning management system
Number of subjects: 66
Study 12919710 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alendronate (ALN)
Number of subjects: 306
Study 10820298 — intervention group
Group type: EXPERIMENTAL
Intervention: Rola Stretcher
Number of subjects: 12
Study 10820298 — intervention group
Group type: EXPERIMENTAL
Intervention: True Back II
Number of subjects: 12
Study 10820298 — intervention group
Group type: COMPARATOR
Intervention: Supine rest
Number of subjects: 12
Study 10820298 — intervention group
Group type: EXPERIMENTAL
Intervention: Firm foam block
Number of subjects: 12
Study 9004094 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-inhibitor benazepril
Number of subjects: 0
Study 1804654 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg sodium benzoate
Number of subjects: 6
Study 1804654 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/kg sodium benzoate
Number of subjects: 6
Study 1804654 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg/kg sodium benzoate
Number of subjects: 6
Study 1804654 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 to 160 mg/kg sodium benzoate
Number of subjects: 6
Study 6383991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceruletide (2 ng/kg/min. i.v.)
Number of subjects: 60
Study 6383991 — intervention group
Group type: COMPARATOR
Intervention: Neostigmin (3 x 0.5 mg/die)
Number of subjects: 60
Study 6383991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceruletide
Number of subjects: 60
Study 6383991 — intervention group
Group type: COMPARATOR
Intervention: Neostigmin
Number of subjects: 60
Study 6383991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceruletide and Neostigmin
Number of subjects: 60
Study 30832624 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based model of ECD intervention
Number of subjects: 1200
Study 30832624 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed model combining group sessions with personalized home visits
Number of subjects: 1200
Study 30832624 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1200
Study 30832624 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arm with quarterly booster visits for 6 months
Number of subjects: 1200
Study 30001746 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotilaner (Credelio™)
Number of subjects: 169
Study 30001746 — intervention group
Group type: COMPARATOR
Intervention: Fipronil
Number of subjects: 169
Study 26702455 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal atomised dexmedetomidine (DEX) 2 μg/kg
Number of subjects: 100
Study 26702455 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 100
Study 24581948 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline infusion (14 patients)
Number of subjects: 67
Study 24581948 — intervention group
Group type: COMPARATOR
Intervention: No catecholamines (53 patients)
Number of subjects: 67
Study 22138037 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy (6 cycles of paclitaxel 70 mg/m(2)/wk [3 weeks on/1 week off])
Number of subjects: 220
Study 22138037 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 220
Study 22138037 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy
Number of subjects: 220
Study 20297616 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg rectal indomethacin
Number of subjects: 200
Study 17397312 — intervention group
Group type: EXPERIMENTAL
Intervention: Power toothbrush (group P)
Number of subjects: 70
Study 17397312 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (group M)
Number of subjects: 70
Study 15730052 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-dilution hemo-filtrate reinfusion (PDHFR)
Number of subjects: 6
Study 15730052 — intervention group
Group type: COMPARATOR
Intervention: Standard hemo-filtrate reinfusion (HFR)
Number of subjects: 6
Study 12518021 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT formula (40% of fat as MCT)
Number of subjects: 19
Study 12518021 — intervention group
Group type: COMPARATOR
Intervention: Control formula (without MCT)
Number of subjects: 19
Study 10911770 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogenized meal (HM)
Number of subjects: 8
Study 10911770 — intervention group
Group type: COMPARATOR
Intervention: Solid-liquid meal (SM)
Number of subjects: 8
Study 8721957 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilaterally antegrade selective digital subtraction angiography (DSA)
Number of subjects: 25
Study 8721957 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilaterally antegrade selective DSA
Number of subjects: 25
Study 8721957 — intervention group
Group type: COMPARATOR
Intervention: Unselective stationary DSA
Number of subjects: 25
Study 1858625 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin pretreatment with treadmill exercise (5000 IU intravenously)
Number of subjects: 14
Study 1858625 — intervention group
Group type: COMPARATOR
Intervention: Heparin calcium injections (10,000 IU subcutaneously)
Number of subjects: 14
Study 6955542 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer screening with mammography and palpation
Number of subjects: 0
Study 6955542 — intervention group
Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 0
Study 31295547 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannum metallicum 30x preparation
Number of subjects: 10
Study 31295547 — intervention group
Group type: COMPARATOR
Intervention: Systematic negative water control experiments
Number of subjects: 10
Study 28276743 — intervention group
Group type: EXPERIMENTAL
Intervention: Social modelling (observing positive treatment effects)
Number of subjects: 59
Study 28276743 — intervention group
Group type: COMPARATOR
Intervention: Control (no difference reported)
Number of subjects: 59
Study 25621236 — intervention group
Group type: EXPERIMENTAL
Intervention: Clotrimazole ear drops
Number of subjects: 214
Study 25621236 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole cream
Number of subjects: 214
Study 25621236 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole ear drops
Number of subjects: 214
Study 24315243 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain communication plus virtual pain coach
Number of subjects: 23
Study 24315243 — intervention group
Group type: COMPARATOR
Intervention: Pain communication only
Number of subjects: 23
Study 21596371 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Approach Test (BAT)
Number of subjects: 73
Study 18761755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) training for nurses
Number of subjects: 80
Study 18761755 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (Control)
Number of subjects: 80
Study 18761755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 80
Study 17409389 — intervention group
Group type: EXPERIMENTAL
Intervention: Real‐rTMS + RealVMC
Number of subjects: 27
Study 17409389 — intervention group
Group type: COMPARATOR
Intervention: Placebo‐rTMS + PlaceboVMC
Number of subjects: 27
Study 17409389 — intervention group
Group type: EXPERIMENTAL
Intervention: Real‐rTMS + PlaceboVMC
Number of subjects: 27
Study 17409389 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo‐rTMS + RealVMC
Number of subjects: 27
Study 15369420 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (ARB)
Number of subjects: 0
Study 15369420 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (ARB)
Number of subjects: 0
Study 15369420 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of trandolapril (ACE inhibitor) and losartan (ARB)
Number of subjects: 0
Study 15369420 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 0
Study 15369420 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril (ACE inhibitor)
Number of subjects: 0
Study 11514487 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse led shared care programme
Number of subjects: 98
Study 11514487 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 98
Study 9344704 — intervention group
Group type: EXPERIMENTAL
Intervention: Linomide
Number of subjects: 0
Study 8518380 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (D) at 4 micrograms/kg/min
Number of subjects: 9
Study 8518380 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside (N) at 0.25 to 1.0 micrograms/kg/min
Number of subjects: 9
Study 8518380 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of dobutamine and nitroprusside
Number of subjects: 9
Study 8518380 — intervention group
Group type: COMPARATOR
Intervention: None (baseline data)
Number of subjects: 9
Study 3088751 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (group 2)
Number of subjects: 28
Study 3088751 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postoperative enteral feeding (group 3)
Number of subjects: 28
Study 3088751 — intervention group
Group type: COMPARATOR
Intervention: Standard intravenous fluids (group 1)
Number of subjects: 28
Study 31653779 — intervention group
Group type: EXPERIMENTAL
Intervention: early‐ACLR
Number of subjects: 121
Study 31653779 — intervention group
Group type: COMPARATOR
Intervention: optional‐delayed‐ACLR
Number of subjects: 121
Study 30400222 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL of agraz nectar
Number of subjects: 40
Study 30400222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 27481624 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention of post-ICU acute hospital rehabilitation including enhanced physiotherapy, nutritional care, information provision, and case management by dedicated rehabilitation assistants.
Number of subjects: 240
Study 27481624 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study 24971661 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 745 (3 mg/kg)
Number of subjects: 0
Study 24971661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22721873 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg alone
Number of subjects: 56
Study 22721873 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan 80 mg with S-amlodipine 5 mg
Number of subjects: 56
Study 22721873 — intervention group
Group type: EXPERIMENTAL
Intervention: S-amlodipine 5 mg alone
Number of subjects: 56
Study 22721873 — intervention group
Group type: COMPARATOR
Intervention: S-amlodipine 5 mg with Telmisartan 80 mg
Number of subjects: 56
Study 20171425 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) formulation of simvastatin 40 mg
Number of subjects: 53
Study 20171425 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release (IR) formulation of simvastatin 40 mg
Number of subjects: 53